https://www.selleckchem.com/products/tepp-46.html
This proof-of-principle study demonstrated that the targeted NGS assay can simultaneously detect both MDS CNVs and somatic mutations, which can provide a more comprehensive genetic profiling for patients with myeloid malignancies using a single assay in a clinical setting. Developing effective interventions to promote successful transition to adulthood for adolescents and young adults (AYA) with spina bifida (S requires input from SB community stakeholders, particularly AYA themselves. The goal of this study was to identify and priori
Like
Comment
Share
